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present in posttransplant biopsies from 1 alcohol userThe purposes of this study were to determine among
only. Alcohol use by alcoholics is uncommon in the first 5a cohort of long-term alcoholic survivors after liver
years after liver transplantation, and alcohol-associatedtransplantation (1) the incidence of alcohol use, (2) its
liver injury is unusual. Mild nonspecific hepatitis is com-effect on allograft integrity and extrahepatic health, and
mon in both alcohol users and nonusers alike. Among a(3) the validity of the pretransplant alcohol prognosis
small subset of alcoholic transplant recipients, drinkingscreening process. Retrospective clinical cohort study
behavior after liver transplantation is associated withof all alcoholic patients undergoing orthotopic liver
considerable morbidity, requiring hospital admissionstransplantation at a single center from February 1987
and occasionally leading to graft loss and death. (HEPA-until January 1991 with follow-up through December
TOLOGY 1997;25:1223-1227.)1994, giving a median duration of follow-up of 63 months
(range, 6-89 months). Multidisciplinary liver trans-
plantation program at a tertiary-care academic medical Orthotopic liver transplantation is an efficacious therapy
center. Fifty alcoholic, long-term liver transplant recipi- for severe liver failure associated with alcoholism. Survival
ents. The frequency of alcohol relapse, defined as any rates after liver transplantation are similar among alcoholics
alcohol use in the period after transplantation, was de- and nonalcoholics.1,2 There is a significant survival advan-
termined by two questionnaire studies and by clinical tage among alcoholics with transplants compared with alco-
follow-up. Allograft integrity was assessed by coded re- holic patients refused transplants on psychiatric grounds or
view of serial percutaneous allograft biopsies. Potential compared with alcoholic controls with severe liver disease in
systemic effects of alcohol relapse were assessed by a simulated mathematical model.2,3 We have shown that
chart review. The alcohol prognosis screening process more than 50% of alcoholics referred to our program are re-
was evaluated by retrospectively comparing pretrans- fused transplants on either medical, surgical, or psychiatric
plant estimates of putative indicators of alcoholism grounds, a rate of refusal that exceeds that for most other
prognosis in posttransplant alcohol users and abstain- chronic liver diseases (unpublished observations).
ers. Thirty-three recipients (66%) consistently denied Alcoholics with end-stage liver disease undergo careful as-
any alcohol use throughout the duration of posttrans- sessment of the risk of recidivism in the future.4 There is a
plant follow-up, whereas 17 (34%) were identified as hav- relatively low incidence of recidivism in short-term periods
ing consumed alcohol at least once since the transplant. of observation after transplantation.2,5-8 More recent studies
There were no significant differences at the time of eval- have suggested that the incidence of recidivism, although
uation between abstainers and alcohol users in age, sex still low compared with incidence with other forms of therapy
distribution, severity of liver dysfunction, median dura- for alcoholism, increases with longer follow-up.9
tion of abstinence, or University of Michigan alcoholism It remains uncertain whether alcohol use after liver trans-
prognosis score. The median interval from transplanta- plantation has untoward consequences for allograft function.
tion to alcohol relapse was 17 months, with a range of 3 Indeed, Bonet et al. have proposed that a relapse of alcohol
to 45 months. Recurrent alcohol use was associated with abuse by alcoholics after liver transplantation may have par-
significant medical complications sufficient to require adoxical benefits, including reducing the incidence of acute
admission to the hospital in 6 patients. One patient died cellular rejection.10 The purposes of this study were (1) to
of graft dysfunction, noncompliance with immunosup- document the incidence of alcohol use among a cohort of long-
pressant medications, and presumed graft rejection term alcoholic survivors after liver transplantation; (2) to
while drinking. Mild or progressive hepatitis, which was determine the effect of alcohol use on allograft integrity and
the most common abnormality in posttransplant liver extrahepatic health in these patients; and (3) in light of these
biopsy findings, was equally distributed between both data, to review the pretransplant alcohol prognosis screening
alcohol users and abstainers and sometimes occurred in process.
the absence of antibody to hepatitis C virus antibodies.
There was a similar frequency of biopsy-proven acute PATIENTS AND METHODS
cellular rejection in alcohol users and abstainers. Typi-
A retrospective review was undertaken of all patients with alcoholcal histological features of alcoholic liver injury were
abuse or dependence, defined according to the Diagnostic and Statis-
tical Manual of Mental Disorders of the American Psychiatric Associ-
ation (3rd ed., revised) (DSM-III-R), who received a liver transplant
Abbreviations: anti-HCV, antibody to hepatitis C virus; HCV, hepatitis C virus. between February 1987 and January 1991.11 Forty-five of the present
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versity of Michigan Medical Center, Ann Arbor, MI. of liver transplantation in alcoholic liver disease.2 All had undergone
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TABLE 1. Demography and Clinical Characteristics of 50 Alcoholic months, compared with 10 of 33 nonusers who had less than
Liver Transplant Recipients 6 months’ abstinence. The duration of time on the liver trans-
plant waiting list was similar in both groups. The UniversityAbstainers Users P
of Michigan alcoholism prognosis score did not distinguish
n 33 17 NS between abstainers and users.
Sex (M/F) 24/9 12/5 NS There were 3 late deaths among the abstaining group as
Age (yr) 46 (31-65) 45 (28-61) NS a result of unexplained hypoglycemia, recurrent hepatitis B
Child’s class infection, and hepatoma, each in 1 case. There was 1 late
A 0 0 death among the alcohol-user group, and this patient will beB 11 3
described below.C 18 11
Retrospective determination of the date of relapse, ac-Incomplete 4 3
cording to the patients’ own reports, was available in 12 sub-Abstinence (mo) 11 (0-180) 4 (0-36) NS
Waiting time (d) 21 (1-152) 15 (0-67) NS jects in the user group. The median interval from trans-
University of Michigan plantation to relapse was 17 months, with a range of 3 to 45
Alcoholism Prognosis Scale 17 (8, 18) 16 (9, 18) NS months. In 6 patients, recurrent alcohol use was associated
with significant medical complications sufficient to require
NOTE. All data are shown as median and range. Abstinence refers to dura- admission(s) to hospital. These events included bouts of un-tion of abstinence at time of evaluation.
controlled drinking followed on separate occasions by delir-
ium tremens and an episode of pneumonia, recurrent celluli-
tis when drinking and ‘‘skin popping’’ cocaine, repeated
episodes of pancreatitis coincident with alcohol use, chole-of factors suggesting a favorable prognosis for sobriety described by
Vaillant, and social stability according to Strauss and Bacon.13,14 static hepatitis associated with a blood alcohol level of 160
Severity of liver disease was assessed using Child-Turcotte-Pugh mg/dL on admission to the hospital, and an upper gastroin-
scores.15 Alcohol use after transplantation was assessed by two for- testinal hemorrhage due to gastritis and admitted alcohol
mal interview studies, in 1988-1989 published in 1992,16 and in use. Finally, 1 patient had graft dysfunction, noncompliance
1992,17 and by clinical surveillance at our outpatient clinics and by with immunosuppressant medications, and presumed graftcontacting primary care physicians until December 1994. A formal
rejection while drinking 3 months after transplantation. Weprospective longitudinal protocol of alcohol use interviews or mea-
decided not to offer this patient retransplantation, and thesurement of blood or urine alcohol levels was not used throughout
patient died. Four of the 6 patients with putative medicalthe duration of the study. Alcohol relapse was defined as any alcohol
use revealed in either interview survey or in the course of clinical complications of alcohol relapse reported initial abstinence
follow-up. Liver biopsies were performed whenever clinically indi- from alcohol for 12 months or greater from the date of trans-
cated on the basis of abnormal results of biochemical tests. For the plantation.
purposes of the study, biopsies were reviewed in blinded fashion Management of alcohol relapse after transplantation was
under code by two pathologists (K.C. and H.D.A.). Acute cellular on a case-by-case basis. For example, 1 patient sought medi-
rejection was always a histological diagnosis according to the criteria cal assistance for a single episode in which she drank 1 quartof Snover.18
of table wine after a family argument. She underwent inpa-Statistics. Qualitative data were compared between users and ab-
tient rehabilitation and has maintained follow-up attendancestainers using x2 tests, and those with continuous variables using
at a support group. She has subsequently remained abstinentWilcoxon’s rank sum test, P values of õ.05 being considered signifi-
cant. Survival was estimated by the Life-Table Analysis method of for more than 4 years. Another patient had repeated hospital
Peto et al.19 admissions for intoxication, pneumonia, delirium tremens,
and a myocardial infarction in the first 4 years after trans-
RESULTS plantation, during which time he refused psychiatric assis-
tance. He then stopped drinking alcohol of his own volition,Clinical Features. Fifty-nine alcoholic patients received
transplants during the period described. There were 9 early and he has remained abstinent for 26 months. In contrast,
other patients within this cohort continue to consume alcoholdeaths due to perioperative death (nÅ 2), poor graft function,
with or without sepsis (n Å 5), graft-vs.-host disease (n Å 1), on an intermittent or regular basis.
Histology. Forty-five explanted livers were reviewed. Alland hepatoma (n Å 1). Three underwent a second trans-
plantation. The median interval from transplantation to showed cirrhosis. None were accompanied by histological fea-
tures of acute alcoholic hepatitis, combining a neutrophilicdeath in this subset was 33 days (range 1-150 days). On
review of patients’ case records, it was considered that they infiltrate, steatosis, Mallory bodies, necrosis of individual he-
patocytes, and debris-filled phagocytes. In 14 explants, thedid not reestablish their health and were consequently un-
able to exercise a choice regarding a return to drinking. They cirrhosis had the appearance of end-stage alcoholic injury
including small nodules, loss of central zones, and steatosis.will not be considered further. Among the remaining cohort
of 50 long-term survivors that forms the basis of the present The frequencies of histological alcoholic liver disease in the
explanted livers were similar in the patients who subse-report, the median duration of follow-up was 63 months and
was ¢4 years in 46 (92%). In this cohort, 33 recipients (66%) quently went on to alcoholic relapse and those who main-
tained sobriety after transplant (Table 2). Thirty-one ex-reported no alcohol use throughout the duration of posttrans-
plant follow-up and are termed alcoholic abstainers, whereas plants lacked etiologic markers, including patterns typical of
alcoholic cirrhosis, and would be classified on histological17 recipients (34%) were identified as having consumed alco-
hol at least once since the transplant and are termed alcohol grounds as cryptogenic. Evidence of other causes of liver in-
jury such as a1-antitrypsin deficiency, primary biliary cirrho-users. Table 1 shows comparative clinical characteristics in
these two subgroups. Abstainers and alcohol users were of sis, or hepatitis B viral infection was found in 9 explants,
always in the patients who subsequently remained abstinent.similar age, sex distribution, and severity of liver dysfunction
as shown by Child-Turcotte-Pugh classification at the time of All posttransplant biopsies have been reviewed in 33 sub-
jects. Data in Table 2 represent the most abnormal biopsythe evaluation.15 There were 4 alcohol abusers (classification
305) in each group, which was not statistically different. The in the biopsy series from each patient. Mild or progressive
hepatitis was the most common abnormality and was equallymedian length of abstinence before evaluation was greater
among abstainers than alcohol users, although this difference distributed between both alcohol users and abstainers. In all
subjects, hepatitis C antibody testing after transplantationdid not reach significance. Nine of 17 recipients who returned
to alcohol use had pre-evaluation abstinence of less than 6 was available for review. Antibody to hepatitis C virus (anti-
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TABLE 2. Histological Features in Explanted Liver and the definition of a relapse. This approach usually relies on
Posttransplant Liver Biopsies the patient’s own report of alcohol drinking, because alcoholic
cirrhotics show a consistent pattern of underestimation whenAbstainers Users
self-reported alcohol use has been corroborated by serial
Explants urine tests.21 It is possible, therefore, that self-reported ac-
n 29 16 counts of consumption have underestimated the true fre-
Small nodules 5 5 quency of alcohol use after transplantation. In contrast, Bird
Mallory’s hyaline 5 4 et al. presumed alcohol use on the basis of liver chemistry
Steatosis 2 1 and biopsy results even when the patient denied it.22 ThisCentral zone loss 6 5
approach carries the contrary risk of overestimating or mis-Cryptogenic cirrhosis 22 9
identifying recidivists. More recently, Howard et al. have re-Alcoholic cirrhosis 7 7
ported on psychiatric interviews in 20 long-term alcoholicAcute alcoholic hepatitis 0 0
Posttransplant biopsy liver transplant survivors and found that 19 of 20 had re-
Subjects studied 20 13 turned to drinking.23 They attribute their much higher alco-
Normal 4 4 hol use to better interview methods, which result when the
Steatosis 1 0 interviewer is independent of the transplant group. However,
Steatosis / inflammation 3 2 this is unlikely to be the only explantation, because the physi-
Mild hepatitis 7 6 cians were aware of the drinking relapse in 13 of 19 cases.Progressive hepatitis 6 2
Lack of a standardized selection process, and inclusion of onlyAcute alcoholic hepatitis 0 1
50% of the cohort who received transplants, also compromiseAcute cellular rejection 8 4
Howard’s data. In the present study, we have tried to over-
NOTE. Data on posttransplant biopsy represent the most abnormal biopsy come the problems inherent in estimating alcohol use by com-
in each biopsy series from each patient. bining serial interview data with documentation at frequent
clinic visits. We realize, however, that only prospective data
gathering and aggressive case follow-up of the nonattenders
would provide more definitive data.HCV) antibodies were present in approximately half of the It is clear from our observations that there is no character-patients with histological hepatitis among both alcohol users istic pattern of posttransplant alcohol use. Indeed, althoughand abstainers (Table 3). Anti-HCV antibodies were common we describe 17 alcoholic transplant recipients who returnedalso in the absence of histological hepatitis in both groups. to alcohol use, this group is made up of 17 individuals whoThere was a similar frequency of biopsy-proven acute cellular each behaved differently. We saw repeated pathologicalrejection in both users and abstainers. One patient, a post- drinking that continued throughout the observation period,transplant alcohol user, showed typical features of alcoholic profound pathological drinking followed by sustained absti-injury on biopsy, including intense central zone steatosis and nence, a single episode of alcohol use leading to rehabilitationstellate perisinusoidal fibrosis. and abstinence, and admitted minor alcohol use. The present
report includes data from our previously published studyDISCUSSION
comparing drinking behavior in alcoholic and nonalcoholic
liver transplant recipients.16 This showed a similar preva-Alcoholic cirrhosis was the preoperative diagnosis in 2,499
liver transplants, or 15.6% of all transplantations performed lence of alcohol use after transplantation in both groups, but
excessive use only occurred in the alcoholic recipients. Simi-in the United States between 1988 and 1993.20 The growth
in the absolute number of liver transplants in alcoholic per- larly, Berlakovich et al. distinguished between ‘‘harmful’’ and
other forms of drinking.9 In the more general literature onsons has occurred against a background of an ongoing debate
on both the practical and ethical implications of offering liver alcoholism, irrespective of liver transplantation, restoration
of a controlled pattern of social alcohol use remains rare.24transplantation to persons with alcoholism.
Previously when we and others have reported our experi- As yet, there are no data to support the contention that alco-
holic liver transplant recipients can achieve a pattern of mod-ence of liver transplantation in patients with end-stage alco-
holic liver disease, we have concentrated on selection, early erate controlled alcohol use.
The data presented here show that whereas chronic hepati-mortality, utilization of resources, or short-term recidivism.
Table 4 summarizes these studies. They show clearly that tis is common, typical alcoholic injury to the grafted liver
is not. In our series, no patient who was actively drinkingmortality for alcoholics does not differ from that reported
in nonalcoholic recipients. Table 4 also shows that alcoholic developed acute alcoholic hepatitis. Only 1 patient who was
actively drinking developed alcoholic-type steatosis with ex-relapse, however defined, is infrequent in the first 24 months
after liver transplantation. The frequency of relapse in- tensive perisinusoidal fibrosis. The etiology of posttransplant
hepatitis in our cohort is unclear. Many patients in both thecreases as the duration of follow-up is extended. Berlakovich
et al. reported on 44 long-term alcoholic survivors after liver user and abstinent groups are anti-HCV antibody positive.
These results are congruent with the frequent observation oftransplantation and found that the frequency of relapse in-
creased from 15% at 1 year to 31% at 3 years.9 In the present anti-HCV and hepatitis C virus (HCV) RNA in the serum of
alcoholic cirrhotics.25,26 However as shown in Table 3, thestudy, we have found a similar incidence of reported alcohol
use (34%), usually beginning more than 12 months after occurrence of hepatitis was poorly associated with anti-HCV.
transplantation, among 50 alcoholics who were long-term
liver transplant survivors. However, the present study also
TABLE 3. Results of HCV Serological Tests, and Histologicalshows alcohol relapse by alcoholics after liver transplantation
Study in Posttransplant Biopsiesis a heterogeneous clinical phenomenon.
Abstainers UsersAlcohol use after transplantation, often labeled as recidi-
vism, is defined inconsistently in various liver transplant
n 23 13studies. Many studies, including our present and previous
anti-HCV positive, hepatitis 7 3reports, have combined all or any alcohol use under the rubric
anti-HCV positive, no hepatitis 3 2‘‘recidivism’’ because, lacking serial prospective measures, we Hepatitis, anti-HCV negative 7 3
feared that significant alcohol use would be missed if some anti-HCV negative, no hepatitis 6 5
degree of moderate or occasional drinking was excluded from
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TABLE 4. Summary of Published Data on Alcohol Use by Alcoholic Patients After Liver Transplantation
No. of Alcoholics
No. of Alcoholics Receiving No. of
Receiving Transplants Alcoholics 1-yr 5-yr Duration Relapse
Study Alcoholism Transplants (Not Study Not Survival Survival of Follow- Relapse Frequency
Author Years Prognosis (Study Cohort) Cohort) Selected Rate (%) Rate up Defined (%)
Kumar5 1982-1988 Abstinent period 52 21 Not stated 74 Not stated Not Any use 12
not required stated (phone
survey)




Knechtle6 1984-1990 Abstinent period 32 9 5 83 71% Not Any use 13
not required stated (psychiatric
interview)
Gish7 1988-1991 Abstinent period 29 0 Not stated 93 Not stated 24 mo Any use 21
not required (prospective
follow-up)
Osorio8 1988-1991 6 Months 43 0 65 100 Not stated 21 mo Any use (mail 19
Abstinence survey)
Berlakovich9 1982-1993 Abstinent period 44 36 Not stated 71 63% 78 mo Any use 32
not required (clinic
follow-up)
Lucey* 1987-1991 Abstinent period 50 9 75 80 77% 63 mo Any use (see 34
not required text)




We recognize that anti-HCV antibody measurements may be prine had been withdrawn. We have inferred that episodes
of cellulitis and of pneumonia were alcohol related becauseinaccurate in patients receiving immunosuppressant medica-
tion. Consequently, the observation that posttransplant hep- they occurred during heavy drinking bouts, even though we
recognize that cellulitis or pneumonia, or for that matter pan-atitis may be due to factors other than HCV would be
strengthened by measures of HCV RNA in serum using poly- creatitis, can arise in liver transplant recipients without alco-
hol exposure. Despite the caveat that it is impossible to bemerase chain reaction, which were not available in the pres-
ent study. Even so, whereas HCV may account for some post- certain that alcohol use contributed to each of the extrahe-
patic phenomena described here, it is our impression thattransplant hepatitis in alcoholic transplant recipients, it is
unlikely to account for all. Previously, Hubscher has shown persistent alcohol abusers experience more medical problems
than their abstinent counterparts and constitute a dispropor-that nonprogressive low-grade hepatitis of uncertain etiology
is common in long-term follow-up biopsies after liver trans- tionate burden on the posttransplant management team.
Therefore, it is our contention that the increased burdenplantation.27 Evidence is accumulating that HCV and alcohol
act synergistically in producing liver damage.25,26 It is of in- of extrahepatic illness in relapsing alcoholic liver transplant
recipients justifies pretransplant selection procedures thatterest, therefore, that in the small sample of anti-HCV–posi-
tive patients in the alcohol-user group that liver injury was aim to identify those at greatest risk of posttransplant alcohol
relapse. This viewpoint begs the question of whether we arenot disproportionately severe.
In our study, alcohol use did not confer any immunosup- able to identify future drinkers. The determination of alcohol
abuse or dependence did not distinguish future users frompressant benefit. Because 80% of acute cellular rejection oc-
curs within the first 8 postoperative weeks, it is unlikely abstainers. In the present study, the prognosis for future
abstinence was assessed in all recipients using the methodthat alcoholic relapse, which usually arises 12 months after
transplantation, would play a significant immunity-modulat- we have described.2,4 This method includes a point system,
which we have advocated as a tracking system rather thaning role.28 Only once did we observe coincident alcohol relapse
and a presumptive, i.e., not biopsy-proven, diagnosis of acute an absolute threshold. As shown in Table 1, there were no
differences in the prognosis scores calculated during pre-cellular rejection, as a result of failure to maintain the pre-
scribed immunosuppressive regimen. It appears uncommon transplant assessment among the subsequently abstinent
and alcohol-using transplant recipients. We suspect that thethat alcoholic patients are derelict with their medications,
even when they are drinking. Indeed, we have previously prognosis scoring system is more valuable than it appears to
be in these data, in part because the major screening processshown that the frequency of admitted failure to take pre-
scribed immunosuppressive medications is similar for alco- for alcoholics to gain access to our liver transplant program
occurs when the patient is referred by the primary care physi-holic and nonalcoholic liver transplant recipients.16
The present study is the first to demonstrate an impact of cian. In a review of 233 patients with alcohol abuse or depen-
dence referred to our center for consideration for liver trans-alcohol use by alcoholic recipients on extrahepatic health.
This arose from our clinical experience in which particular plantation, the Michigan Prognosis Score was 12 points or
greater in 78.5%, suggesting that stable, insightful alcoholicspatients developed clinical syndromes that seemed directly
associated to pathological drinking. In some cases the associ- were most likely to be referred.29
We therefore advocate maintaining a selection process thatation was incontrovertible, such as intoxication and delirium
tremens. Other episodes, such as recurrent pancreatitis, were screens prospective alcoholic liver transplant candidates us-
ing a broad-based instrument such as the University of Mich-probably alcohol associated given the patients acknowledged
use of alcohol and the recurrence of pancreatitis after azathio- igan Alcoholism Prognosis Score rather than a time-based
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